| Exploring the role of IL-36 cytokines as a new target in psoriatic disease H Iznardo, L Puig International journal of molecular sciences 22 (9), 4344, 2021 | 55 | 2021 |
| IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications L Iznardo, Helena: Puig Int. J. Mol. Sci 23 (16), 9479, 2022 | 38 | 2022 |
| Lentigo maligna: clinical presentation and appropriate management H Iznardo, C Garcia-Melendo, O Yélamos Clinical, cosmetic and investigational dermatology, 837-855, 2020 | 36 | 2020 |
| Dual inhibition of IL-17A and IL-17F in psoriatic disease H Iznardo, L Puig Therapeutic Advances in Chronic Disease 12, 20406223211037846, 2021 | 35 | 2021 |
| Propranolol‐resistant infantile hemangioma successfully treated with sirolimus VL Dávila‐Osorio, H Iznardo, E Roé, L Puig, E Baselga Pediatric Dermatology 37 (4), 684-686, 2020 | 33 | 2020 |
| Real‐world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis H Iznardo, E Vilarrasa, A López‐Ferrer, L Puig British Journal of Dermatology 185 (3), 660-662, 2021 | 28 | 2021 |
| The safety of brodalumab for the treatment of psoriasis H Iznardo, L Puig Expert opinion on drug safety 19 (4), 365-372, 2020 | 26 | 2020 |
| Efficacy and safety of JAK1 inhibitor abrocitinib in atopic dermatitis H Iznardo, E Roé, E Serra-Baldrich, L Puig Pharmaceutics 15 (2), 385, 2023 | 17 | 2023 |
| The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives H Iznardo, L Puig Expert Review of Clinical Immunology 17 (2), 187-199, 2021 | 15 | 2021 |
| Excellent response to secukinumab in an infant with severe generalized pustular psoriasis C López‐Sánchez, LM Falla, E Roé‐Crespo, JI Arostegui, A Mozos, ... The Journal of Dermatology 48 (6), 907-910, 2021 | 14 | 2021 |
| Good response to pulsed dye laser in patients with capillary malformation‐arteriovenous malformation syndrome (CM‐AVM) H Iznardo, E Roé, L Puig, M Vikula, C López‐Sánchez, E Baselga Pediatric Dermatology 37 (2), 342-344, 2020 | 12 | 2020 |
| Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry C Muniesa, F Gallardo, I García‐Doval, MT Estrach, A Combalia, ... Journal of the European Academy of Dermatology and Venereology 37 (1), 57-64, 2023 | 8 | 2023 |
| Beyond plaque psoriasis–pathogenesis and treatment of other psoriasis phenotypes H Iznardo, L Puig Current Opinion in Rheumatology 34 (4), 225-234, 2022 | 6 | 2022 |
| Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome H Iznardo, C Bredrup, S Bernal, T Gladkauskas, JM Mascaró Jr, E Roé, ... American Journal of Medical Genetics Part A 188 (4), 1233-1238, 2022 | 4 | 2022 |
| Iceberg sign as a dermoscopic clue of actinic keratosis neglecta JF Mir‐Bonafé, E Rozas‐Muñoz, J Dalmau, M Mir‐Bonafé, H Iznardo, ... Journal of the European Academy of Dermatology and Venereology 33 (7), e254-e256, 2019 | 4 | 2019 |
| Shear wave elastography as a potential tool for quantitative assessment of sinus tracts fibrosis in hidradenitis suppurativa. H Iznardo, E Vilarrasa, E Roé, L Puig Journal of the European Academy of Dermatology & Venereology 36 (8), 2022 | 2 | 2022 |
| Net‐like superficial lymphatic malformation H Iznardo, E Baselga, A Mozos, J Szafranska, R Orellana‐Fernández, ... Pediatric Dermatology 38 (2), 516-517, 2021 | 2 | 2021 |
| Propranolol-resistant infantile hemangioma successfully treated with sirolimus VLD Osorio, H Iznardo, E Roe, L Puig, E Baselga J Ped Dermatol, 1-3, 2020 | 2 | 2020 |
| Retiform purpura in an 80‐year‐old woman. E Carmona‐Rocha, H Iznardo, L Puig International Journal of Dermatology 61 (10), 2022 | 1 | 2022 |
| Dupilumab treatment in paediatric atopic dermatitis (2 to 18 years): Spanish multicentre retrospective real-life study H Iznardo, E Roé, A Vicente, C Prat, M Casals, A Martín-Santiago, ... Clinical and Experimental Dermatology, llae300, 2024 | | 2024 |
